{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:26:57Z","timestamp":1788010017890,"version":"build-2784847793"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ajp.2021.102963","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T23:40:44Z","timestamp":1639698044000},"page":"102963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Randomised, placebo-controlled trial on topiramate add-on therapy for weight reduction and symptomatology in overweight\/obese persons with schizophrenia"],"prefix":"10.1016","volume":"68","author":[{"given":"Miyuru","family":"Chandradasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera","family":"Ruwanpriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silumini","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layani","family":"Rathnayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.L.A.","family":"Kuruppuarachchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2021.102963_bib1","first-page":"270","article-title":"Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial","volume":"14","author":"Behdani","year":"2011","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.ajp.2021.102963_bib2","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","author":"Chan","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ajp.2021.102963_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40596-018-0920-8","article-title":"Subspecialisation in postgraduate psychiatry and implications for a resource-limited specialised child and adolescent mental health service","volume":"43","author":"Chandradasa","year":"2019","journal-title":"Acad. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102963_bib4","first-page":"18","article-title":"Topiramate\u2019s effectiveness on weight reduction in overweight\/obese persons with schizophrenia: study protocol for a randomized controlled trial","author":"Chandradasa","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.ajp.2021.102963_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4038\/jpgim.8112","article-title":"Association of duration of untreated psychosis and functional level, in first episode of schizophrenia attending an outpatient clinic in Sri Lanka","volume":"3","author":"Chandradasa","year":"2016","journal-title":"J. Postgrad. Inst. Med."},{"key":"10.1016\/j.ajp.2021.102963_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1192\/S2056474000001756","article-title":"Child and youth mental health in post-war Sri Lanka","volume":"14","author":"Chandradasa","year":"2017","journal-title":"BJPsych Int."},{"key":"10.1016\/j.ajp.2021.102963_bib7","doi-asserted-by":"crossref","first-page":"e746","DOI":"10.4088\/JCP.15r10373","article-title":"Efficacy for psychopathology and body weight and safety of topiramate-antipsychotic cotreatment in patients with schizophrenia spectrum disorders: results from a meta-analysis of randomized controlled trials","volume":"77","author":"Correll","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102963_bib8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s40273-014-0182-6","article-title":"Cost-effectiveness analysis of qsymia for weight loss","volume":"33","author":"Finkelstein","year":"2015","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.ajp.2021.102963_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/13651501.2018.1449864","article-title":"Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials","author":"Goh","year":"2019","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.ajp.2021.102963_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/acps.12245","article-title":"A systematic review of controlled interventions to reduce overweight and obesity in people with schizophrenia","author":"Hjorth","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2021.102963_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102174","article-title":"Unresolved issues for utilization of atypical antipsychotics in schizophrenia: antipsychotic polypharmacy and metabolic syndrome","author":"Jeon","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ajp.2021.102963_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.wnf.0000172994.56028.c3","article-title":"Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain","volume":"28","author":"Ko","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ajp.2021.102963_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5694\/mja16.00650","article-title":"Cardiovascular disease in patients with schizophrenia","volume":"206","author":"Kritharides","year":"2017","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ajp.2021.102963_bib14","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-clinpsy-032813-153657","article-title":"Excess early mortality in schizophrenia","author":"Laursen","year":"2014","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.ajp.2021.102963_bib15","doi-asserted-by":"crossref","unstructured":"Misra, A., Bhardwaj, S., 2014. Obesity and the metabolic syndrome in developing countries: Focus on South Asians, in: Nestle Nutrition Institute Workshop Series. S. Karger AG, pp. 133\u2013140. https:\/\/doi.org\/10.1159\/000354952.","DOI":"10.1159\/000354952"},{"key":"10.1016\/j.ajp.2021.102963_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2010.02.001","article-title":"Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial","volume":"118","author":"Narula","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2021.102963_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"Nishida","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2021.102963_bib18","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2147\/NDT.S125367","article-title":"Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Okuyama","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ajp.2021.102963_bib19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.ajp.2021.102963_bib20","doi-asserted-by":"crossref","DOI":"10.24869\/psyd.2017.108","article-title":"Causes of mortality in schizophrenia: an updated review of European studies","author":"Piotrowski","year":"2017","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.ajp.2021.102963_bib21","first-page":"17","article-title":"Prevalence and trends of metabolic syndrome among adults in the Asia-pacific region: a systematic review","author":"Ranasinghe","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ajp.2021.102963_bib22","unstructured":"SLCTR [WWW Document], n.d. URL \u3008https:\/\/slctr.lk\/trials\/slctr-2017\u2013003\u3009 (accessed 10.28.21)."},{"key":"10.1016\/j.ajp.2021.102963_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/acps.12631","article-title":"Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials","volume":"134","author":"Zheng","year":"2016","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201821004196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201821004196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:41:25Z","timestamp":1761756085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201821004196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":23,"alternative-id":["S1876201821004196"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2021.102963","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomised, placebo-controlled trial on topiramate add-on therapy for weight reduction and symptomatology in overweight\/obese persons with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2021.102963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102963"}}